Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists
![](/.imaging/webp/sanofi-templates/article-hero-w768/dam/campus-sanofi-kw/new/science/science-hero-(8).webp/jcr:content/science%20hero%20(8).webp)
Objective and Method
![](/dam/jcr:65aa5311-dbef-4fe4-975c-14a2408e31b1/Asset%204@4x-100%20(4).webp)
Consensus based on literature supporting clinical presentation and recommendations
Literature Analysis on LOPD Symptoms (Orthopedics): Hierarchy of Evidence
![](/dam/jcr:4d0d43b1-38db-4392-99af-811d0e064f19/Asset%206@4x%20(1).webp)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:5c66aa72-f11d-4d97-bd6b-9922b56bbbe5/bh.jpg)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:d4f01f5b-a628-4746-8c3d-44b3a3c011bf/Asset%209@4x%20(1).webp)
Conclusion
![](/.imaging/webp/sanofi-templates/w1080/dam/campus-sanofi-kw/new/science/Asset-7-2x-(2).webp/jcr:content/Asset%207@2x%20(2).webp)
Rheumatology-Specific
Recommendation
Testing for Pompe disease must be done if any one specialty-specific symptom plus elevated CK/LDH/ALT/AST or a family history of unexplained muscle weakness is present.
*The age of patients with pediatric/juvenile LOPD ranges from 1 to 17 years.
Abbreviations
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CK: Creatine kinase; DBS: Dried blood spot testing; KSA: Kingdom of Saudi Arabia; LDH: Lactate dehydrogenase; LGMW: Limb–girdle muscle weakness; LOPD: Late-onset Pompe disease; UAE: United Arab Emirates.
Reference
- Al Shehri A, Al-Asmi A, Al Salti AM, et al. A multidisciplinary perspective addressing the diagnostic challenges of late-onset Pompe disease in the Arabian Peninsula region developed from an Expert Group Meeting. J Neuromuscul Dis. 2022;9(5):661–673.